Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Ferrer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Acta Otorrinolaringologica Espanola|April 20, 2010
[Malignant otitis externa. Our experience]Palmira Pérez, Maria J Ferrer, Aranzazu Bermell, et al.
AIDS Reviews|June 17, 2009
Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral reviewJosé A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 27, 2018
NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIVAnna Prats, Estela López-Masramon, Núria Pérez-Álvarez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2013
A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screenJose A Muñoz-Moreno, Anna Prats, Núria Pérez-Álvarez, et al.
Medicina Clinica|June 13, 2013
[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables]José A Muñoz-Moreno, Maria J Fuster-Ruiz de Apodaca, Carmina R Fumaz, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
AIDS Research and Human Retroviruses|October 11, 2008
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patientsJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Journal of Neurovirology|May 11, 2010
Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?Jose A Muñoz-Moreno, Carmina R Fumaz, Anna Prats, et al.
Plos One|August 31, 2017
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot studyJose A Muñoz-Moreno, Anna Prats, José Moltó, et al.
Plos One|September 20, 2014
Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variablesJose A Muñoz-Moreno, Núria Pérez-Álvarez, Amalia Muñoz-Murillo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Otorrinolaringologica Espanola|April 20, 2010
[Malignant otitis externa. Our experience]Palmira Pérez, Maria J Ferrer, Aranzazu Bermell, et al.
AIDS Reviews|June 17, 2009
Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral reviewJosé A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 27, 2018
NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIVAnna Prats, Estela López-Masramon, Núria Pérez-Álvarez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2013
A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screenJose A Muñoz-Moreno, Anna Prats, Núria Pérez-Álvarez, et al.
Medicina Clinica|June 13, 2013
[Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables]José A Muñoz-Moreno, Maria J Fuster-Ruiz de Apodaca, Carmina R Fumaz, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
AIDS Research and Human Retroviruses|October 11, 2008
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patientsJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Journal of Neurovirology|May 11, 2010
Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?Jose A Muñoz-Moreno, Carmina R Fumaz, Anna Prats, et al.
Plos One|August 31, 2017
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot studyJose A Muñoz-Moreno, Anna Prats, José Moltó, et al.
Plos One|September 20, 2014
Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variablesJose A Muñoz-Moreno, Núria Pérez-Álvarez, Amalia Muñoz-Murillo, et al.
Pageof 2